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Artemin, a Novel Member of the GDNF Ligand Family,
Supports Peripheral and Central Neurons
and Signals through the GFRa3±RET Receptor Complex
et al., 1998; Milbrandt et al., 1998; reviewed by Grondin
and Gash, 1998). However, the GDNF ligands also influ-
ence a broad spectrum of other neuronal populations
in both the CNS and PNS. GDNF and NTN both support
the survival of many peripheral neurons in culture, in-
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and Jeffrey Milbrandt*³ cluding sympathetic, parasympathetic, sensory, and en-
teric neurons (Buj-Bello et al., 1995; Ebendal et al., 1995;*Department of Pathology and
Department of Internal Medicine Trupp et al., 1995; Kotzbauer et al., 1996; Heuckeroth
et al., 1998). In contrast, PSP does not share any of²Department of Neurology and
Department of Molecular Biology these peripheral activities but does support the survival
of dopaminergic midbrain neurons and motor neuronsand Pharmacology
Washington University (Milbrandt et al., 1998). Despite the fact that GDNF acts
on many cell populations in vitro, analysis of GDNFSchool of Medicine
St. Louis, Missouri 63110 knockout mice revealed that the major developmental
importance of GDNF is in the enteric nervous system
and in kidney organogenesis, both of which are lost in
GDNF null mice (Moore et al., 1996; Pichel et al., 1996;Summary
Sanchez et al., 1996).
Although members of the TGF-b superfamily, theThe glial cell line±derived neurotrophic factor (GDNF)
GDNF ligands utilize a receptor system that is moreligands (GDNF, Neurturin [NTN], and Persephin [PSP])
similar to that observed for many cytokines, in that asignal through a multicomponent receptor system com-
common signaling component is used by multiple li-posed of a high-affinity binding component (GFRa1±
gands, and an additional protein binds to the ligandGFRa4) and a common signaling component (RET).
with high affinity and provides specificity. The commonHere, we report the identification of Artemin, a novel
signaling component for the GDNF ligands is the RETmember of the GDNF family, and demonstrate that it is
receptor tyrosine kinase, which is expressed at allthe ligand for the former orphan receptor GFRa3±RET.
known sites of GDNF ligand action and is activated byArtemin is a survival factor for sensory and sympa-
GDNF or NTN stimulation in multiple in vitro paradigmsthetic neurons in culture, and its expression pattern
(Durbec et al., 1996; Jing et al., 1996; Treanor et al.,suggests that it also influences these neurons in vivo.
1996; Trupp et al., 1996; Worby et al., 1996; Creedon etArtemin can also activate the GFRa1±RET complex
al., 1997). GFRa1-GFRa4 comprise a structurally noveland supports the survival of dopaminergic midbrain
family of glycosyl-phosphatidyl inositol± (GPI-) an-neurons in culture, indicating that like GDNF (GFRa1±
chored proteins that function as high-affinity bindingRET) and NTN (GFRa2±RET), Artemin has a preferred
proteins for the GDNF ligands. Results from in vitro ex-receptor (GFRa3±RET) but that alternative receptor
periments by multiple groups together indicate thatinteractions also occur.
GFRa1±RET is the preferred receptor for GDNF, and
GFRa2±RET is the preferred receptor for NTN; however,
cross talk between the different receptors is possibleIntroduction
(Jing et al., 1996; Treanor et al., 1996; Baloh et al., 1997;
Buj-Bello et al., 1997; Jing et al., 1997; Klein et al., 1997;Neurotrophic factors represent a heterogeneous group of
Sanicola et al., 1997; Suvanto et al., 1997). Recent analy-signaling molecules that orchestrate multiple aspects
sis of GFRa1-deficient mice indicated that GFRa1 is theof the development and maintenance of the central and
only physiologically critical GDNF coreceptor in kidneyperipheral nervous systems (CNS and PNS). The GDNF
family of ligands, consisting of glial cell line±derived organogenesis and enteric nervous system develop-
neurotrophic factor (GDNF; Lin et al., 1993), Neurturin ment (Cacalano et al., 1998; Enomoto et al., 1998). How-
(NTN; Kotzbauer et al., 1996), and Persephin (PSP; Mil- ever, GDNF-deficient mice have greater losses in periph-
brandt et al., 1998) comprise a subfamily of ligands eral ganglia than GFRa1-deficient mice, suggesting that
within the TGF-b superfamily of signaling molecules that GDNF can utilize another receptor to support the sur-
have neurotrophic properties. Interest in the GDNF fam- vival of peripheral neurons, likely GFRa2±RET (Cacalano
ily was initially fueled largely by the ability of all known et al., 1998; Enomoto et al., 1998). PSP cannot signal
members to support the survival of dopaminergic mid- through either the GFRa1±RET or GFRa2±RET receptor
brain neurons and spinal and facial motor neurons in complexes (Milbrandt et al., 1998), but a recent report
both in vitro survival and in vivo injury paradigms, identi- indicated that PSP binds to GFRa4, a receptor currently
fying them as potential therapeutic agents in the treat- only identified in the chicken (Enokido et al., 1998).
ment of neurodegenerative diseases (Lin et al., 1993; GFRa3 was first identified as an expressed sequence
Henderson et al., 1994; Oppenheim et al., 1995; Horger tag (EST) that is homologous to GFRa1 and GFRa2 (Jing
et al., 1997; Baloh et al., 1998; Naveilhan et al., 1998;
Widenfalk et al., 1998; Worby et al., 1998). However,³ To whom correspondence should be addressed: (e-mail: jeff@
milbrandt.wustl.edu). analysis in transfected cells indicated that GFRa3 could
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Figure 1. Artemin Is a Member of the GDNF
Family of Ligands
(A) Alignment of predicted mature human Ar-
temin (ART) with the other GDNF family li-
gands. Conserved cysteine residues are in
bold type and shaded.
(B) Alignment of human and mouse prepro
Artemin. The putative signal sequence is
shaded, and putative RXXR cleavage sites
are designated by thick lines. Arrowheads de-
note the location of the two introns in the
ARTEMIN gene.
(C) A schematic diagram of the location of
the two introns in the Artemin cDNA and their
splicing. cDNAs containing a second starting
methionine were also identified by RACE PCR
from some human cDNA libraries (Met*); how-
ever, a similar message was not identified in
mouse, and mouse genomic sequence does
not contain a methionine in this position. Ma-
ture Artemin protein generated from either of
the human messages would be identical.
not form a functional receptor with RET for any of the Results
known GDNF ligands (Baloh et al., 1998; Worby et al.,
1998). GFRa3 expression is much more restricted than Identification and Analysis of the ARTEMIN
Gene and cDNAGFRa1 or GFRa2, with high-level expression observed
only in developing peripheral nerves and ganglia (Baloh In an effort to identify additional members of the GDNF
family, we searched multiple databases using the BLASTet al., 1998; Naveilhan et al., 1998; Widenfalk et al., 1998;
Worby et al., 1998). Furthermore, one report demon- 2.0 algorithm (Altschul et al., 1997), with mature NTN
protein sequence as a query. A search of the highstrated that in sensory neurons of the trigeminal gan-
glion, GFRa3 is expressed in a population of neurons throughput genome sequences (HTGS) database re-
vealed two human bacterial artificial chromosome (BAC)distinct from GFRa1 and GFRa2 and likely overlaps with
RET (Naveilhan et al., 1998). Therefore, structural simi- clones (AC005038, AC005051) containing a homologous
open reading frame (hORF) similar but not identical tolarity, expression, and functional data together sug-
gested that GFRa3 can interact with RET and that an- human GDNF, NTN, or PSP. A search of the EST data-
base using the predicted 39 untranslated region of thisother member of the GDNF ligand family remained to
be identified. hORF revealed two ESTs (AA931637 and AA533512),
suggesting that the hORF represents an expressedHere, we report the identification of a novel member
of the GDNF ligand family, which we have named Ar- gene. We also identified by PCR a fragment from mouse
genomic DNA corresponding to the same hORF. To iso-temin. Like GDNF and NTN, Artemin supports the sur-
vival of several peripheral neuron populations and can late full length mRNA species encoded for by this hORF,
we performed rapid amplification of cDNA ends (RACE)also support dopaminergic neurons of the ventral mid-
brain. However, Artemin appears to be the only member PCR on multiple human and mouse tissue cDNA librar-
ies. Analysis of the full length cDNAs from human andof the GDNF family that binds to and activates the
GFRa3±RET receptor complex. Interestingly, Artemin mouse confirmed that the hORF represents a member of
the GDNF ligand family, which we have named ARTEMINcan also activate the GFRa1±RET receptor complex, in-
dicating that like GDNF (GFRa1±RET) and NTN (GFRa2± (Figure 1).
Alignment of the predicted mature Artemin proteinRET), Artemin has a preferred receptor (GFRa3±RET),
but alternative receptor interactions are possible. with the other GDNF ligands indicates that Artemin is
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most similar to NTN and PSP (z45% identity) and some- hybridization (Baloh et al., 1998; Trupp et al., 1998; Wid-
enfalk et al., 1998; Worby et al., 1998; Yu et al., 1998).what more divergent from GDNF (z36% identity; Figure
1A). Analysis of the predicted full length Artemin protein The expression of Artemin in the developing nerve
roots at E14 suggested that it is produced by Schwannrevealed the presence of a signal peptide for secretion
and a large proregion separated from the mature region cell precursors or immature Schwann cells. To investi-
gate if Schwann cells express Artemin, we performedby multiple conserved RXXR furin protease cleavage
sites (Figure 1B). Comparison of the human mRNA se- RT-PCR analysis on cDNA samples from adult sciatic
nerve and from Schwann cells cultured from early post-quence with the genomic locus revealed the presence
of two introns in the Artemin coding region (Figures 1B natal rats (Figure 2E). Artemin is expressed at much
higher levels in immature Schwann cells in culture thanand 1C), the second of which is positioned similarly to
the introns found in the prodomains of the other GDNF by mature myelinating Schwann cells of the adult sciatic
nerve. Interestingly, Artemin expression is upregulatedfamily ligands.
Analysis of markers present on the ARTEMIN-con- in the distal nerve segment after sciatic transection, a
paradigm in which Schwann cells reacquire an imma-taining BAC clones indicated that the ARTEMIN gene is
located on chromosome 1p32±33, flanked by markers ture state to support regenerating axons (reviewed by
Scherer, 1997). These data indicate that Schwann cellsD1S190-ARTEMIN-D1S211 (telomeric to centromeric).
produce Artemin and suggest that Artemin expression
is regulated appropriately to influence developing and
Artemin Is Expressed during Embryogenesis regenerating peripheral neurons.
and in Adult Tissues
As an initial survey of Artemin expression in adult and
Artemin Is a Survival Factor for Peripheralembryonic human tissues, we probed a human master
and Central Neurons In VitroRNA blot (MRB) array using a fragment of the human
GDNF and NTN, but not PSP, support the survival ofArtemin cDNA (Figures 2A and 2B). Relatively low-level
several peripheral neuronal populations in vitro (Buj-expression was observed in many peripheral adult tis-
Bello et al., 1995; Ebendal et al., 1995; Trupp et al., 1995;sues, with the highest level in the pituitary gland, pla-
Kotzbauer et al., 1996; Milbrandt et al., 1998). As showncenta, and trachea. Among human fetal tissues, kidney
above, expression of Artemin suggests it may influenceand lung showed the highest level of expression. Ar-
developing peripheral neurons, like other members oftemin expression was low in the adult and fetal brain.
the GDNF family. Therefore, we cultured neurons fromInterestingly, low-level brain expression was present in
the dorsal root, trigeminal, nodose, and superior cervicalstructures of the basal ganglia (subthalamic nucleus,
ganglia (SCG) from neonatal rats to compare Artemin'sputamen, substantia nigra) and in the thalamus, sug-
ability to support their survival with that of GDNF, NTN,gesting that Artemin may influence subcortical motor
and PSP (Figure 3). Like GDNF and NTN, Artemin sup-systems. Expression was also observed in the spinal
ported the survival of a subset of sensory neurons fromcord; however, this RNA preparation contains DRG ma-
both the dorsal root ganglion (DRG) and the trigeminalterial as well as spinal cord, which likely contributes to
ganglion (TG), whereas PSP did not (Figures 3A and 3C).the observed expression (Clontech; see Figure 2C).
Interestingly, in both of these populations of sensory
neurons, Artemin supported a larger number of neurons
than GDNF and NTN and supported a similar (DRG) orArtemin Is Expressed in Sites Consistent with
a Role in Paracrine and/or Target Influence a greater number (TG) of neurons than NGF. Dose±
response analysis of Artemin's survival-promoting ef-of Developing Peripheral Neurons
To determine more precise localization of Artemin ex- fect on DRG neurons revealed an EC50 of 1±3 ng/mL,
z10210 M (Figure 3B). We also examined Artemin's abilitypression during embryogenesis, we performed in situ
hybridization on embryonic day 14 (E14) rats. No signal to support the survival of visceral sensory neurons of
the nodose ganglion (NG), which consists of a largewas observed in the brain or spinal cord at this embry-
onic age. The most striking expression was observed number of neurons responsive to the neurotrophin
BDNF (Lindsay et al., 1985). Artemin, GDNF, and NTNin the nerve roots, but not the developing neurons, of the
dorsal root ganglia (Figure 2C). Furthermore, significant supported similar numbers of NG neurons, and each
factor yielded equal or greater survival promotion thandiffuse expression was also observed around the supe-
rior mesenteric artery, corresponding to either the sur- BDNF, similar to previous reports (Trupp et al., 1995;
Kotzbauer et al., 1996) (Figure 3D).rounding mesenchyme or expression by cells of the
artery itself (Figure 2D). These data suggest the possibil- We further assessed Artemin's ability to support sym-
pathetic neurons of the SCG, which are responsive toity that Artemin may act as a survival/trophic factor for
peripheral neurons either in a paracrine fashion for de- GDNF (Trupp et al., 1995) and NTN (Kotzbauer et al.,
1996). Artemin also supported the survival of SCG neu-veloping sensory neurons of the DRG or as a target-
derived factor for autonomic innervation of the superior rons in culture, although fewer neurons were supported
by Artemin than by GDNF or NTN, and in contrast tomesenteric artery. Interestingly, among potential GFRa
receptors, expression of Artemin is most complemen- the sensory neurons examined above, none of the GDNF
family ligands supported as many neurons as NGF (Fig-tary with that of the orphan GFRa3, which is expressed
at high levels in peripheral ganglia but which has no ure 3E). Therefore, similar to GDNF and NTN, and consis-
tent with its embryonic expression pattern, Artemin isdetectable expression in the developing CNS by in situ
Figure 2. Analysis of Artemin RNA Expression in Developing and Adult Tissues
(A) MRB (Clontech) analysis of Artemin expression in human adult and fetal tissues. A 32P-labeled fragment of the human Artemin cDNA was
used as a probe. Artemin showed a broad expression pattern in peripheral tissues, with little signal visible in brain. Low-level signal is observed,
however, in the adult substantia nigra, thalamus, and subthalamic nucleus of the CNS. The spinal cord sample contains DRG material, which
may contribute to the signal observed in this tissue sample (Clontech).
(B) Location of human tissues on the MRB array.
(C) In situ hybridization analysis of Artemin expression in embryonic rat suggests a role in peripheral neuron development. Saggital section
of an E14 rat. The orientation of the section is top, rostral and left, dorsal. While no signal is visible in the DRG themselves at this age, clear
Artemin expression is observed in tissue representing the exiting nerve roots (NR). A sense version of the rat Artemin 33P-labeled probe did
not hybridize to any tissues (data not shown). The expression below the liver (large arrow) likely represents a lateral extension of the superior
mesenteric artery (see [D]) but may also correspond to a pancreatic duct or the common bile duct.
(D) A parasaggital section of E14 rat in the same orientation as (A), showing high-level Artemin expression surrounding the developing superior
mesenteric artery (SMA). Signal corresponding to what is likely developing cartilage is observed in the lower right of the photomicrograph.
As in (A), no expression was visible in the brain or spinal cord of embryos at this age.
(E) Semiquantitative RT-PCR analysis demonstrates regulated Artemin expression by Schwann cells. All cDNAs were normalized to GAPDH
levels as described in Experimental Procedures. Primary cultures of Schwann cells in neonatal rats (PS) express Artemin, whereas myelinating
Schwann cells from the adult sciatic nerve (N) show much lower level expression. However, Artemin is upregulated in the distal segment of
the sciatic nerve following nerve transection. Abbreviations: 16 h, 16 hours; 3d, 3 days; and 7d, 7 days).
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Figure 3. Artemin Supports the Survival of
Peripheral and Central Neurons in Culture
(A) Histogram of the number of surviving DRG
neurons cultured from P1 rats in the presence
of the indicated factors. Neurons were plated
directly into the presence of the indicated fac-
tors and cultured for 3 days. Artemin (ART)
supported the survival of as many or more
DRG neurons than GDNF or NTN. The mean
and SEM are shown (n 5 5±11).
(B) Dose-response histogram of Artemin sur-
vival promotion in P1 rat DRG neurons. Ar-
temin promoted the survival of cultured DRG
neurons with an EC50 of z3 ng/mL (10210 M).
The mean and SEM are shown (n 5 5).
(C) Trigeminal ganglion (TG) neurons cultured
from P1 rats. Cells were plated directly into
factors, and survival was assessed after 3
days in culture. Artemin's survival-promoting
activity in the TG was significantly greater
than GDNF, NTN, or NGF. The mean and SEM
are shown (n 5 4).
(D) NG neurons cultured from P1 rats. Neu-
rons were plated directly into medium con-
taining BDNF (100 ng/mL) or the GDNF family
ligands. Artemin, like GDNF and NTN, also
supports the survival of placodally derived
visceral sensory neurons of the NG. The mean
and SEM from a representative experiment
are shown (n 5 2).
(E) SCG from P1 rats. SCG neurons were iso-
lated and maintained in the presence of NGF
for 5 days. The culture medium was changed,
and the indicated factors were added for an
additional 3 days, after which the number of
surviving neurons was counted. Artemin,
GDNF, and NTN support a similar number of
sympathetic neurons of the SCG. The mean
and SEM are shown (n 5 2±8).
(F) Dopaminergic ventral midbrain neurons from E14 rats (EVM). After 3 days in culture in the presence of the indicated factor, the number
of TH1 neurons was determined. Results from two independent experiments are shown as the percentage of surviving TH1 neurons over
control (mean and SEM, n 5 9±15).
Note: factors were added to cultures at 50 ng/mL, unless otherwise indicated.
a survival factor for sensory and sympathetic peripheral induced a strong differentiation response in the line SH-
SY5Y, similar to retinoic acid treatment (Figures 4A±4C).neurons in culture.
As shown above, Artemin expression was not ob- Furthermore, like GDNF, Artemin stimulated prolifera-
tion in the NBL-S line, as measured by bromodeoxyuri-served in the brain or spinal cord of embryonic rats at
E14 but was present at very low levels in human fetal dine (BrdU) incorporation (Figure 4D). Lines that do not
express RET (CHP126, CHP134, SAN) and do not re-brain and in some adult brain regions by blot analysis.
Therefore, to compare Artemin's ability to influence cen- spond to GDNF or NTN (M. G. T. unpublished data) also
did not respond to Artemin (data not shown). Both thetral neurons to the other GDNF ligands, and to contrast
its peripheral survival-promoting activities, we cultured SH-SY5Y and NBL-S lines express GFRa1±GFRa3 and
therefore did not suggest the usage of a particular core-dopaminergic neurons from the rat embryonic ventral
midbrain. Interestingly, although there is no apparent ceptor by Artemin.
In summary, all of the biological responses of ArteminArtemin expression in the ventral midbrain at this age,
Artemin also supported the survival of dopaminergic in peripheral and central neurons and in neuronal cell
lines suggest that Artemin utilizes receptor componentsmidbrain neurons (Figure 3F). Therefore, Artemin can
influence central as well as peripheral neuronal survival, similar to or overlapping with GDNF and NTN.
and receptors for Artemin are present in both of these
populations. Artemin Signals through RET Using the Former
Orphan GFRa3 as a CoreceptorNeuroblastoma cell lines are derivatives of peripheral
sympathetic neuroblast tumors that respond to GDNF Because Artemin supports the survival of neuronal pop-
ulations that overlap with GDNF and NTN, and becauseand NTN and display a variety of GFRa±RET receptor
profiles (Hishiki et al., 1998; M. G. T., unpublished data). its activity correlated with RET expression in neuro-
blastoma cell lines, we first investigated Artemin's abilityTherefore, we investigated Artemin's ability to influence
several of these neuronal cell lines to determine if re- to activate RET in primary cultured SCG neurons and
in the responsive neuroblastoma cell line NBL-S (Figuressponsive cells had a consistent receptor profile. Artemin
Neuron
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Figure 4. Artemin Induces Differentiation and
Proliferation in Neuroblastoma Cell Lines
SH-SY5Y neuroblastoma cells were cultured
in the presence of no factor (Cn; [A]), 10 mM
all-trans retinoic acid (RA; [B]), or 50 ng/mL
Artemin (ART; [C]). Like RA, a known inducer
of differentiation in these cells, Artemin in-
duced clear differentiation of SH-SY5Y cells,
as illustrated by their robust neurite out-
growth and neuronal morphology.
(D) Histogram of BrdU incorporation by
NBL-S neuroblastoma cells in the presence
of 50 ng/mL of the indicated factor. Artemin,
like GDNF, induced robust proliferation of
NBL-S cells, whereas PSP did not.
5A and 5B). Like GDNF, Artemin induced tyrosine phos- all GDNF family receptor interactions because of the
observation that RET can modulate receptor bindingphorylation of RET in SCG neurons and in the NBL-S
cell line, and this activation was effective in eliciting (Sanicola et al., 1997). To directly test which receptor
combinations can form functional receptors for Artemindownstream signaling, as measured by activation of the
mitogen-activated protein (MAP) kinase pathway. Fur- on cells, we transiently transfected the individual GFRa
coreceptors together with the Gal4±Elk1/Gal4±luciferasethermore, pretreatment of the NBL-S cell line with the
enzyme PI-PLC, which specifically cleaves GPI-anchored reporter system into fibroblasts that stably express RET.
This system, which utilizes the ability of the Gal4±Elk1proteins from the cell surface, abrogated Artemin's abil-
ity to activate RET and downstream MAP kinase signal- fusion protein to respond to MAP kinase activity and
activate transcription of the Gal4±luciferase reporter,ing (Figure 5B). Therefore, these data indicate that like
the other members of the GDNF family, Artemin signals has been used previously to monitor NGF±TrkA activa-
tion of MAP kinase in PC12 cells (Vossler et al., 1997;through the RET receptor tyrosine kinase and requires
a GPI-anchored coreceptor to do so. York et al., 1998) and GDNF/RET activation of MAP ki-
nase in neuroblastoma cell lines (Worby et al., 1996,To investigate which if any of the known coreceptors
Artemin can utilize to activate RET, we first assessed 1998). Consistent with previous reports in multiple sys-
tems, GDNF can activate RET signaling in fibroblastsits ability to directly bind to soluble Fc-fusion forms of
GFRa1±GFRa3 (Figures 5C±5E). In this assay, GFRa1± expressing GFRa1±RET or GFRa2±RET but not GFRa3±
RET (Baloh et al., 1997, 1998; Jing et al., 1997; SanicolaFc was able to bind to both GDNF and NTN with similar
affinity but not to PSP or Artemin. GFRa2±Fc bound to et al., 1997; Suvanto et al., 1997; Worby et al., 1998)
(Figure 6A). As predicted from the binding data, ArteminNTN but not GDNF or Artemin, consistent with a previous
report that GDNF can only bind to GFRa2±Fc in the was able to activate GFRa3±RET but not GFRa2±RET
receptor complexes. Interestingly, Artemin was also ablepresence of RET (Sanicola et al., 1997). Interestingly,
the former orphan receptor GFRa3±Fc was able to bind to activate RET in cells expressing GFRa1±RET, al-
though to a lesser degree than GDNF. RT-PCR analysisto Artemin but not to any of the other GDNF family
members, consistent with the inability of GFRa3 to form of cDNA from GFRa1±RET-expressing cells confirmed
that expression of GFRa1 did not induce the expressiona functional receptor complex for GDNF, NTN, or PSP
with RET (Baloh et al., 1998; Worby et al., 1998). Each of GFRa3, a possible alternative explanation for their
responsiveness to Artemin (data not shown).of the receptor bodies bound to their respective ligands
with an apparent Kd of z3 nM, which is similar to the To confirm these results in a more neuronal cell line,
we also transiently transfected receptor componentspreviously reported affinity between GFRa1±Fc and
GDNF in this assay (Sanicola et al., 1997). Therefore, into neuroblastoma cells from the NLF line that express
GFRa2 and RET and natively respond to GDNF by RETArtemin can bind to the former orphan receptor GFRa3
with an affinity similar to that of GDNF and NTN binding and MAP kinase activation (M. G. T., unpublished data)
(Figure 6B). NLF cells transfected with GFRa1 respondedto their cognate receptors.
The binding data above suggest that GFRa3±RET is more intensely to GDNF and became responsive to Ar-
temin, confirming the results observed in fibroblasts.the functional receptor for Artemin; however, direct
binding studies alone have been unreliable in predicting Furthermore, transfection of GFRa3, but not GFRa2, into
Artemin Signals through GFRa3±RET
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Figure 5. Artemin Activates RET in Neurons and Binds to GFRa3±Fc Receptor Bodies
(A) Artemin activates RET and downstream signaling in primary cultured SCG neurons. Neurons were treated with either no factor (Cn), GDNF,
or Artemin (ART) at 50 ng/mL. Cell lysates were immunoprecipitated with anti-phosphotyrosine antibodies and separated by SDS-PAGE, and
immunoblot analysis was performed with anti-RET antibodies to determine the status of RET tyrosine phosphorylation (RET). A portion of the
total lysate was removed before immunoprecipitation, run on an SDS-PAGE gel, and immunoblotted with anti-phospho-MAPK antibodies
(MAPK). Stimulation of SCG neurons by either GDNF or Artemin led to activation of RET and the MAP kinase pathway downstream.
(B) Artemin activates RET in NBL-S neuroblastoma cells, and this activation is dependent upon a GPI-anchored protein. NBL-S cells were
stimulated and analyzed as above (2PI-PLC), and a parallel set of cells was pretreated with the enzyme PI-PLC, which specifically cleaves
GPI-anchored proteins from the cell surface (1PI-PLC). Removal of GPI-anchored proteins vastly depleted the ability of Artemin to activate
RET or MAPK signaling. NGF activation of MAPK after PI-PLC treatment is shown as a control for cell viability (NGF).
(C±E) Direct binding of GFRa1±Fc (C), GFRa2±Fc (D), and GFRa3±Fc (E) receptor bodies to the GDNF ligands. Microtiter plates coated with
GDNF, NTN, ART, or PSP were treated with increasing concentrations of soluble GFRa±Fc fusion proteins. Plates were then washed, and
bound receptor bodies were detected with anti-human Fc antibodies conjugated to HRP. Binding was measured in a plate reader with the
chromogenic HRP substrate 3,39,5,59-tetramethylbenzidine (measured at 450 nm; A450). Error bars in the figure represent the standard deviation
of duplicates from a representative experiment. Both GDNF and NTN bound to GFRa1±Fc bodies in this assay with similar affinity; however,
only NTN binding to GFRa2±Fc was detected. Artemin is the only ligand capable of direct binding to GFRa3±Fc.
NLF cells allowed them to respond to Artemin stimula- neural crest (DRG, TG) and placodally derived (NG) sen-
sory neurons. Furthermore, Artemin can also supporttion. Transfection of GFRa3 also decreased the ability of
NLF cells to respond to GDNF, presumably because the survival of at least one population of CNS neurons
(dopaminergic midbrain neurons). Artemin signals throughcytomegalovirus promoter± (CMV-) driven overexpres-
sion of GFRa3 decreases the relative amount of GFRa2± the RET receptor tyrosine kinase and represents the
sought after ligand for the former orphan coreceptorRET complexes on the cells, thereby decreasing the
number of functional GDNF receptors. GFRa3, which together with RET represents the pre-
ferred multicomponent receptor for Artemin signaling.In summary, direct binding data and receptor activa-
tion experiments in vitro together indicate that Artemin
is the only known GDNF family ligand for the GFRa3±RET
Artemin/GFRa3±RET Signaling in the PNSreceptor complex, but like GDNF and NTN, it can also
Expression analysis of Artemin in adult human tissuesactivate the GFRa1±RET receptor complex.
indicated that it is found at low levels in many peripheral
tissues. Little expression was observed in the CNS, and
in situ hybridization analysis of developing rat embryosDiscussion
at E14 indicated that by far, the highest level of expres-
sion corresponded to regions that are likely to influenceWe have reported the identification of Artemin, a novel
member of the GDNF family of ligands. Artemin supports the development of peripheral neurons. Furthermore,
Artemin is expressed by cultured Schwann cells and isthe survival of neurons from all peripheral ganglia exam-
ined thus far, including sympathetic neurons (SCG) and upregulated after nerve injury, suggesting that glia are
Neuron
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Figure 6. Artemin Activates GFRa3±RET and GFRa1±RET Receptor Complexes on Transfected Cells
Receptor activation in the presence of defined coreceptor components. MG87 fibroblasts stably expressing RET (RET-3T3; [A]) or NLF
neuroblastoma cells (NLF; [B]) were transiently transfected with an expression plasmid for the indicated coreceptor or the CMV plasmid with
no insert (Control), together with the Gal4±Elk/Gal4±luciferase reporter system. Data are presented as fold activation by dividing luciferase
activity in the treatment conditions by the no treatment control, and error bars represent the standard deviation of duplicate measurements
from a representative experiment. In RET-expressing fibroblasts, GDNF was able to activate RET/MAPK signaling in cells transfected with
GFRa1 or GFRa2 but not GFRa3. Neurturin acted similarly to GDNF with all receptors (data not shown). Artemin activates cells expressing
GFRa1±RET or GFRa3±RET but not GFRa2±RET. NLF neuroblastoma cells express GFRa2±RET and therefore natively respond to GDNF but
not Artemin. Transfection of GFRa1 or GFRa3, but not GFRa2, into NLF cells allowed it to respond to Artemin stimulation.
a major source of peripheral Artemin expression. This Because Artemin is the only ligand that can activate
the GFRa3±RET receptor complex, these neurons maygeneral expression pattern is strikingly complementary
to that observed for GFRa3, which is expressed at high represent neurotrophin-independent cells that critically
depend on Artemin for their proper development and/levels only in the developing and adult sensory and sym-
pathetic ganglia of the PNS (Baloh et al., 1998; Naveilhan or postnatal survival. It will be interesting to determine
if the different members of the GDNF ligand family, likeet al., 1998; Widenfalk et al., 1998; Worby et al., 1998).
Given the complementary expression patterns, the dem- the neurotrophins, support the development/matura-
tion/survival of distinct subsets of peripheral neuronsonstration that Artemin is the only ligand for GFRa3±
RET, and the ability of Artemin to support developing that are either spatially or temporally independent from
neurotrophin influence.peripheral neurons in culture, we believe that the Ar-
temin/GFRa3±RET system represents an important neu-
rotrophic influence in PNS development. Artemin and Central Neurons
Artemin was also able to support the survival of dopa-Studies of the neurotrophins using knockout mice and
ligand±receptor expression analysis in developing pe- minergic ventral midbrain neurons in culture. Since
GFRa3 expression was not observed in this area duringripheral ganglia have elegantly established that specific
subsets of PNS sensory neurons are supported by par- development or in adulthood by several groups (Baloh
et al., 1998; Trupp et al., 1998; Widenfalk et al., 1998;ticular members of the neurotrophin family (reviewed
by Lewin and Barde, 1996; Snider and Wright, 1996). Worby et al., 1998; Yu et al., 1998), this survival-promot-
ing effect is presumably due to Artemin's ability to alsoHowever, even in the DRG, where this analysis has been
most extensive, there still remain neurons whose devel- activate the GFRa1±RET receptor complex, which is
highly expressed in these neurons during developmentopmental and/or mature trophic factor dependence is
unclear. A large percentage of adult DRG neurons (Treanor et al., 1996; Baloh et al., 1997; Horger et al.,
1998). No Artemin expression was detected by in situ(z60%±70%) express RET, and these are largely distinct
from TrkA- and parvalbumin-expressing neurons (mark- hybridization in the developing rat brain at a time when
these neurons are responsive to Artemin in vitro (E14),ers for NGF- and NT-3-supported neurons, respectively),
suggesting that they are not influenced by neurotrophins suggesting that this effect is only pharmacologically rel-
evant. However, we cannot exclude that at other embry-(Molliver et al., 1997; Bennett et al., 1998). Recently, it
was shown that GDNF is capable of supporting the sur- onic ages, Artemin may be expressed in the developing
ventral midbrain or other regions of the CNS. Further-vival of a group of neurotrophin-independent neurons
(small neurons that bind the lectin IB4) and that these more, blot analysis showed low-level Artemin expres-
sion in the adult substantia nigra, suggesting that Ar-neurons express either one or both of the competent
GDNF receptors (GFRa1±RET or GFRa2±RET) (Molliver temin could influence these neurons in adulthood. This
raises the possibility that although GFRa3±RET is theet al., 1997; Bennett et al., 1998). However, z30%±40%
of the RET-expressing DRG neurons are not IB4 binding, preferred receptor for Artemin, it may utilize the alterna-
tive GFRa1±RET receptor in vivo, particularly to influ-indicating that many additional DRG neurons exist that
may be supported by Artemin or other GDNF ligands. ence neurons in the CNS.
Although a comparison of GFRa1±GFRa3 expression
has not been performed in the DRG, analysis in the Specificity and Cross Talk in the GDNF
Ligand±GFRa Systemtrigeminal ganglion revealed that GFRa3 appears to be
expressed in a population of neurons distinct from those A schematic interaction diagram of the GDNF ligands
and the GFRa receptors is presented in Figure 7. Similarexpressing GFRa1 and GFRa2 (Naveilhan et al., 1998).
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interactions identified in vitro is often necessary to un-
derstand results of in vivo analysis of neurotrophic factor
influences.
Results from direct binding and RET activation experi-
ments presented here further suggest that like the
GDNF±GFRa2 interaction, the Artemin±GFRa1 interac-
tion appears to be dependent on the presence of RET,
as direct binding of Artemin to GFRa1±Fc or GDNF to
GFRa2±Fc receptor bodies was not observed (Sanicola
et al., 1997; Figures 6C and 6D). This may be due to
the nature of the binding assay, which utilizes soluble
receptor bodies binding to immobilized ligand. Alterna-
tively, this may reflect an additional level of specificity
available to the GDNF ligand±GFRa system, in cases
where the GFRa coreceptors are expressed in the ab-
sence of RET (Baloh et al., 1997; Trupp et al., 1997;Figure 7. Schematic Diagram of Ligand±Receptor Interactions in
Golden et al., 1998; Yu et al., 1998). In these situationsthe GDNF Ligand Family Deduced from Multiple Experimental Para-
(i.e., GFRa1 in injured peripheral nerve and GFRa2 ex-digms In Vitro
pression in cerebral cortex), in which coreceptors areLarge arrows indicate preferred ligand±receptor interactions,
whereas smaller arrows indicate alternate receptor interactions. expressed in trans and are hypothesized to secrete or
GFRa1±RET is the most promiscuous member of the receptor family, present ligand±coreceptor complexes to cells or axons
with the ability to interact with three of the four ligands, whereas expressing RET, only the RET-independent subset of
GFRa3±RET is the least, in that it can only interact with Artemin. binding interactions would be possible.
Although the importance of the cross talk between alternate ligand±
With the data rapidly accumulating from the Humanreceptor pairs is not fully understood, studies of GFRa1-deficient
Genome Project, complete lists of the members of neu-mice indicate that at least one of these interactions (GDNF±GFRa2±
RET) is likely to occur in vivo (Cacalano et al., 1998; Enomoto et al., rotrophic gene families will soon be available, allowing
1998). As indicated, a receptor named GFRa4 has been isolated consideration of an extensive number of potential influ-
from the chicken; however, a mammalian homolog has not yet been ences on neurons. This will facilitate more rapid identifi-
reported. cation of those influences that are most important in
neuronal development/maintenance and those that can
be manipulated advantageously for therapeutic inter-
to many other ligand±receptor systems, including the vention in diseases of the nervous system.
neurotrophins, the system is characterized by having
preferred ligand±receptor pairs; however, cross talk be- Experimental Procedures
tween the different ligands and receptors is apparent.
Identification and Cloning of the Human and Mouse ArteminThe addition of Artemin to this diagram reveals several
BAC clones containing sequence from the human ARTEMIN genenew features. First, both direct receptor binding experi-
were identified by searching (BLAST 2.0 algorithm; Altschul et al.,
ments and receptor activation experiments presented 1997) the HTGS database, with mature human NTN protein se-
here indicate that Artemin is the only GDNF family ligand quence as a query. Sequence from these clones was used to design
capable of utilizing the GFRa3±RET receptor complex. primers that were then used to PCR amplify the mature Artemin
protein coding sequence from human genomic DNA, and theseOne additional study indicated that GDNF was able bind
products were blunt cloned into the EcoRV site of pBluescriptto GFRa3 in the presence of RET (Trupp et al., 1998);
(Stratagene) and sequenced completely on both strands. Primershowever, this interaction was of low affinity, in that it
designed from this sequence were also used to PCR amplify a
required cross-linking to be observed, and its relevance fragment of mouse Artemin from mouse genomic DNA that was
is unclear, because it does not lead to RET activation cloned as above, and subsequently, mouse BAC genomic libraries
in multiple experimental paradigms in vitro (Baloh et al., were screened by this PCR reaction to identify a BAC clone con-
taining the mouse Artemin gene.1998; Trupp et al., 1998; Worby et al., 1998; Figure 6).
Primers were made from human and mouse Artemin genomicSecond, the GFRa1±RET receptor complex is highly pro-
sequence to perform RACE PCR to obtain the 59 end of the Arteminmiscuous, and although results from most in vitro para-
cDNA from several tissue libraries. PCR fragments were blunt cloned
digms agree that it is the preferred receptor for GDNF, as above and sequenced entirely. Human RACE products were ob-
it is possible that NTN and Artemin may also utilize the tained from Marathon RACE cDNA libraries (Clontech) from pituitary,
GFRa1±RET receptor complex in some systems in vivo. placenta, and kidney. Mouse RACE products were obtained from
an E18 mouse MARATHON RACE library. Complete double strandedRecent observations regarding differences in peripheral
sequence of cloned PCR fragments from genomic DNA and cDNAneuron losses between GDNF and GFRa1-deficient
was performed to generate contigs of the human and mouse cDNAs.mice suggest that GDNF can use GFRa2±RET as a re-
At least two independent clones of each PCR fragment were se-
ceptor in vivo and confirm that alternative ligand± quenced. Genomic sequence of mouse BAC clone restriction frag-
receptor interactions may have biological importance in ments (subcloned into pBluescript) and direct sequence of the hu-
the GDNF family (Cacalano et al., 1998; Enomoto et al., man BAC clone were used to confirm the cDNA sequence. Intron
locations in the cDNA and splicing were confirmed by sequencing1998). Furthermore, a recent paper analyzing neuro-
PCR-amplified fragments from human and mouse cDNA librariestrophin knockout mice concluded that NT-3 can signal
that cross both introns.through TrkB in vivo, an interaction observed many
years earlier in vitro but that was not believed to be Production of Recombinant Artemin Protein
relevant in vivo (Ip et al., 1993; Farinas et al., 1998). A PCR fragment was generated corresponding to the predicted
mature human Artemin coding sequence (Figure 1A), with an NdeITherefore, consideration of all possible ligand±receptor
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site and an 8-histidine tag on the 59 end and a KpnI site on the 39 Proliferation and Differentiation of Neuroblastoma Cell Lines
For differentiation of SH-SY5Y cells, cells were plated at 2 3 105end, and then cloned directly into the corresponding sites of the
pET30a(1) bacterial expression vector (Novagen). Recombinant hu- cells/ml/well in 12-well tissue culture plates. After 1 day in culture,
cells were either left untreated or stimulated with 50 ng/mL Arteminman Artemin protein was produced and purified in the E. coli strain
BL21 as described previously for NTN (Creedon et al., 1997). Recom- or 10 mM retinoic acid (RA). Three days after factor addition, dif-
ferentiation was assessed, and cells were photographed. For thebinant GDNF, NTN, and PSP were obtained from Genentech.
NBL-S proliferation assay, cells were plated at 5 3 104 cells/well on
48-well plates in standard medium, either without treatment or in
RNA Blot, RT-PCR, and In Situ Hybridization Analysis the presence of 50 ng/mL of GDNF, Artemin, or PSP. Actively divid-
of Artemin Expression ing cells undergoing DNA synthesis 30 hr after factor addition were
The human MRB containing normalized samples of poly(A) RNA detected with the BrdU (colorimetric) cell proliferation assay kit ac-
was used as described by the manufacturer's instructions (Clon- cording to the manufacturer's instructions (Boehringer-Mannheim).
tech). The blot was probed with a random hexamer 32P-labeled cDNA
probe (nucleotides 478±793), and signals were visualized with a Functional Analysis of Ret Phosphorylation
PhosphorImager (Molecular Dynamics). In situ hybridization analysis and MAP Kinase Activation
of fresh frozen E14 rat embryos was performed as described (Araki Western blot analysis of Ret phosphorylation and MAP kinase acti-
and Milbrandt, 1996). A fragment of the rat cDNA (nucleotides 359± vation were performed as described (Baloh et al., 1997; Creedon et
642) was generated by PCR, cloned into pBluescript, and confirmed al., 1997). SCG neurons were dissected from P1 rats and maintained
by sequence. Sense and antisense 33P-labeled RNA probes were in NGF-containing medium for 5 days, after which they were de-
generated from the rat Artemin cDNA fragment. No signal was de- prived of NGF by switching to NGF-free medium in the presence of
tected with the sense probe on any tissue samples. anti-NGF antibodies. After 2 hr without NGF, neurons were switched
Cultures of purified Schwann cells from neonatal rats were per- to medium containing NGF, GDNF, or Artemin at 50 ng/mL for 20 min.
formed as described (Brockes et al., 1979). Sciatic nerve transection Cells were washed in cold PBS and collected in immunoprecipitation
in adult rats and generation of reverse transcribed cDNA libraries buffer. The lysates were incubated with 30 mL agarose-conjugated
are also described elsewhere (Araki and Milbrandt, 1996; Baloh et anti-phosphotyrosine antibodies (Calbiochem) at 48C for 1 hr. Beads
al., 1997). The cDNA samples were normalized to levels of glyceral- were then washed with immunoprecipitation buffer, resuspended
dehyde 3-phosphate dehydrogenase (GAPDH). The primers used in SDS sample buffer, and boiled for 5 min. Samples were separated
were Fwd, 59-TCG CGA CGG TCC CTC ACC GGT CTT-39; and Rev, by SDS-PAGE and transferred to nitrocellulose membranes. Mem-
59-GCA CGA GCC GCT GCA GAA GCG GAA-39. RT-PCR was per- branes were blocked for 1 hr at 258C in TBS containing 5% dry milk,
formed using the following conditions: 958C for 2 min; (958C for 20 incubated overnight at 48C with a 1:300 dilution of anti-Ret antibody
s; 548C for 30 s; 728C for 30 s) 3 35 cycles; and 728C for 2 min. (C-19; Santa Cruz), and then washed (three times in TBS containing
Products were separated on a 3% agarose gel and stained with 0.1% Tween-20) and incubated in a 1:10,000 dilution of anti-rabbit
ethidium bromide. antibodies conjugated to horseradish peroxidase (HRP) (Jackson
Immunoresearch). Membanes were washed three times, incubated
with SuperSignal ULTRA (Pierce) for 5 min, and then exposed toNeuron Survival Assays
film. NBL-S cells were plated at 3 3 105 cells/well in 6-well platesCultures were performed by standard methods and are described
and after 46 hr switched to low-serum (0.5%) medium for 2 hr, andelsewhere (Kotzbauer et al., 1994; Kotzbauer et al., 1996; Milbrandt
then stimulated with factors (50 ng/mL) for 20 min. Cells were thenet al., 1998). All peripheral neuron cultures were derived from postna-
collected and analyzed as above. For MAP kinase assays, a portiontal day 1 (P1) Sprague-Dawley rats (Harlan Sprague-Dawley, IN).
of the total lysate was removed before immunoprecipitation, run onFor SCG neurons, after dissection and dissociation, neurons were
out by SDS-PAGE, and immunoblotted with an anti-phospho-MAP-plated on collagen-coated 24-well tissue culture plates and main-
kinase antibody (New England Biolabs). For PI-PLC treatment, atained in NGF-containing medium (AM50) for 5 days, after which
parallel set of NBL-S cells was plated as above but treated with 500they were either kept in AM50 or switched to medium containing
mU/mL of PI-PLC (Boehringer-Mannheim) for 1 hr and then washedneutralizing anti-NGF antibodies plus GDNF, NTN, PSP, ART (50
with PBS and stimulated with factors as above.ng/mL where not noted otherwise), or no factors. Cultures were
maintained for 3 days, after which they were fixed in 4% paraformal-
Analysis of Direct Binding of GFRa±Fc Receptordehyde and stained with toluidine blue, and surviving neurons were
Bodies to GDNF Ligandscounted. For NG and DRG neuron cultures, dissociated neurons
GFRa1±Fc, GFRa2±Fc and GFRa3±Fc fusion proteins were obtainedwere plated directly into NGF (for dorsal root ganglia), BDNF (for
from R & D Systems. Binding assays were performed similarly tonodose ganglia, 100 ng/mL), or one of the GDNF ligands in serum-
those previously described (Sanicola et al., 1997). Recombinantcontaining medium (AM50 with anti-NGF in antibodies), and cells
GDNF, NTN, Artemin, PSP, or BSA (Pierce) was coated to Nunc-surviving after 3 days in culture were counted as above. Trigeminal
Immuno MaxiSorp microtiter plates at 325 ng/mL in TBS (10 mMganglia were dissected, dissociated, and plated directly into me-
Tris-HCl [pH 7.5] and 150 mM NaCl) for 1 hr at 258C. Plates weredium containing NGF or the indicated GDNF ligands, and the number
washed (three times in TBS-0.03% Tween-20) and then blockedof surviving cells was assessed after 3 days in vitro. For all cultures
(blocking solution: TBS-1% BSA) for 1 hr at 258C. Receptor bodiessystems, 2±3 independent experiments were performed.
diluted in blocking solution were added and incubated for 2 hr atFor E14 ventral mesencephalon cultures, the entire mesencepha-
258C, washed five times, and then incubated with a 1:10,000 dilutionlon was removed into cold Leibovitz's L15 1 6 mg/ml glucose, and
of HRP-conjugated anti-human Fc antibodies in blocking solutionthe tissue was kept on ice throughout the dissection. Following
(Jackson Immunoresearch) for 45 min at 258C. Finally, wells weredissection, the tissue was digested in a mixture of dispase (1 mg/
washed five times, and the presence of HRP was assayed by theml; Sigma) and collagenase (1 mg/ml; Worthington Biochemical) for
addition of the chromogenic substrate 3,39,5,59-tetramethylbenzi-25 min. Tissue was then washed twice with modified N2 media and
dine for 5 min. The reaction was stopped by adding an equal volumetriturated 35 times. Cell density and viability were assessed with a
of 0.5 M H2SO4, and color was measured in a plate reader at 450hemocytometer to count trypan blue± excluding cells. Cells were
nm. Nonspecific binding of receptor bodies to the plates was mea-plated at 20,000 cells/well on 8-well chamber slides (coated with 125
sured in BSA-coated wells, and this binding was subtracted from allng/mL poly-D-lysine and 25 ng/mL laminin) in serum-free medium
other measurements. All experiments were performed in duplicate.consisting of Dulbecco's Modified Eagle Medium/Hams F12 (1:1),
1 mg/mL bovine serum albumin (BSA), 5 mM insulin, 10 nM proges-
terone, 100 mM putrescine, 30 nM selenium, 10 ng/mL rat transferrin, Transient Transfections and Luciferase Assays
The generation of the expression plasmids for rat GFRa1 and human100 U/mL penicillin, and 100 U/mL streptomycin. Factors were
added within 15 min of plating. After 3 days in culture, cells were GFRa2 and of MG87 fibroblasts stably expressing human RET (RET-
3T3) were described in detail previously (Baloh et al., 1997; Creedonfixed and stained for tyrosine hydroxylase, and the number of tyro-
sine hydroxylase staining± (TH1) neurons was counted. et al., 1997). For generation of the GFRa3 expression plasmid, a
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fragment containing the complete coding region of human GFRa3 Buj-Bello, A., Adu, J., Pinon, L.G., Horton, A., Thompson, J., Rosen-
thal, A., Chinchetru, M., Buchman, V.L., and Davies, A.M. (1997).was PCR amplified from a human pituitary cDNA library, and this
Neurturin responsiveness requires a GPI-linked receptor and thefragment was directly cloned into the KpnI and BamHI sites of pCB6
Ret receptor tyrosine kinase. Nature 387, 721±724.(Brewer, 1994) by using sites engineered into the oligonucleotides.
The Gal4±Elk1 chimera expression plasmid was a gift of P. Stork Cacalano, G., Farinas, I., Wang, L.-C., Hagler, K., Forgie, A., Moore,
(Vollum Institute, Oregon Health Sciences University). Transfections M., Armanini, M., Phillips, H., Ryan, A.M., Reichardt, L.F., et al.
were performed with the Superfect reagent (Qiagen) according to (1998). GFRa1 is an essential receptor component for GDNF in the
the manufacturer's instructions. Cells were plated at 85,000 cells/ developing nervous system and kidney. Neuron 21, 53±62.
well in 12-well plates and transfected with the reporter plasmids Creedon, D.J., Tansey, M.G., Baloh, R.H., Osborne, P.A., Lampe,
(250 ng/well Gal4±luciferase, 50 ng/well Gal4±Elk), CMV-lacZ (50 P.A., Fahrner, T.J., Heuckeroth, R.O., Milbrandt, J., and Johnson,
ng/well) for transfection normalization, a CMV-GFRa (500 ng/well) E.M.J. (1997). Neurturin shares receptors and signal transduction
expression plasmid, and 650 ng/well pBluescript as carrier, for a pathways with glial cell line±derived neurotrophic factor in sympa-
total of 1.5 mg DNA/well. RET-3T3 fibroblasts were exposed to DNA/ thetic neurons. Proc. Natl. Acad. Sci. USA 94, 7018±7023.
Superfect mixtures in an incubator at 378C overnight, washed and
Durbec, P., Marcos-Gutierrez, C.V., Kilkenny, C., Grigoriou, M., War-
placed in low-serum (0.5%) medium, and stimulated with 50 ng/
tiowaara, K., Suvanto, P., Smith, D., Ponder, B., Costantini, F.,
mL factor for 6±8 hr before collection (48 hr posttransfection). NLF
Saarma, M., et al. (1996). GDNF signaling through the Ret receptor
neuroblastoma cells were exposed to DNA/Superfect mixtures for
tyrosine kinase. Nature 381, 789±793.
2 hr, placed in full-serum medium overnight for recovery, and then
Ebendal, T., Tomac, A., Hoffer, B.J., and Olson, L. (1995). Glial cellswitched to low-serum (0.5%) medium containing 50 ng/mL of factor
line±derived neurotrophic factor stimulates fiber formation and sur-for 24 hr before collection (48 hr posttransfection). Measurements
vival in cultured neurons from peripheral autonomic ganglia. J. Neu-of luciferase and b-galactosidase activity were made with a lumino-
rosci. Res. 40, 276±284.meter and performed as described (Svaren et al., 1998). The average
Enokido, Y., de Sauvage, F., Hongo, J.-A., Ninkina, N., Rosenthal,luciferase activity of duplicate samples was normalized to b-galac-
A., Buchman, V.L., and Davies, A.M. (1998). GFRa4 and the tyrosinetosidase activity of the cotransfected lacZ reporter, and fold activa-
kinase Ret form a functional receptor complex for persephin. Curr.tion was calculated by dividing the treatment conditions by the no
Biol. 8, 1019±1022.treatment control.
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Acknowledgments have deficits in the enteric nervous system and kidneys. Neuron 21,
317±324.
We thank S. Audrain for her outstanding technical support with
Farinas, I, Wilkinson, G.A., Backus, C., Reichardt, L.F., and Patapou-DNA sequencing; Yutaka Homma for the rat Artemin probe; Rakesh
tian, A. (1998). Characterization of neurotrophin and Trk receptorNagarajan and Brian Becknell for advice regarding RT-PCR experi-
functions in developing sensory ganglia: direct NT-3 activation ofments; and Alexander Gorodinsky, Allen Bruce, and Judy Golden
TrkB neurons in vivo. Neuron 21, 325±334.for helpful discussions. This work was supported by National Insti-
Golden, J.P., Baloh, R.H., Kotzbauer, P.T., Lampe, P.A., Osborne,tutes of Health grants R01 AG13729 and R01 AG13730 and Genen-
P.A., Milbrandt, J., and Johnson, E.M., Jr. (1998). Expression oftech. Washington University, E. M. J., and J. M. may receive income
neurturin, GDNF, and their receptors in the adult mouse CNS. J.based on a license to Genentech.
Comp. Neurol. 398, 139±150.
Grondin, R., and Gash, D.M. (1998). Glial cell line±derived neuro-
Received November 16, 1998; revised November 29, 1998. trophic factor (GDNF): a drug candidate for the treatment of Parkin-
son's disease. J. Neurol. 245 (suppl.), 35±42.
Henderson, C.E., Phillips, H.S., Pollock, R.A., Davies, A.M., Lemeulle,References
C., Armanini, M., Simpson, L.C., Moffet, B., Vandlen, R.A., Koliatsos,
V.E., and Rosenthal, A. (1994). GDNF: a potent survival factor forAltschul, S.F., Madden, T.L., Schaffer, A.A., Zhang, J., Zhang, Z.,
motoneurons present in peripheral nerve and muscle. Science 266,Miller, W., and Lipman, D.J. (1997). Gapped BLAST and PSI-BLAST:
1062±1064.a new generation of protein database search programs. Nucleic
Acids Res. 25, 3389±3402. Heuckeroth, R.O., Lampe, P.A., Johnson, E.M., and Milbrandt, J.
(1998). Neurturin and GDNF promote proliferation and survival ofAraki, T., and Milbrandt, J. (1996). Ninjurin, a novel adhesion mole-
enteric neuron and glial progenitors in vitro. Dev. Biol. 200, 116±129.cule, is induced by nerve injury and promotes axonal growth. Neuron
Hishiki, T., Nimura, Y., Isogai, E., Kondo, K., Ichimiya, S., Nakamura,17, 353±361.
Y., Ozaki, T., Sakiyama, S., Hirose, M., Seki, N., et al. (1998). GlialBaloh, R.H., Tansey, M.G., Golden, J.P., Creedon, D.J., Heuckeroth,
cell line±derived neurotrophic factor/neurturin-induced differentia-R.O., Keck, C.L., Zimonjic, D.B., Popescu, N.C., Johnson, E.M.J.,
tion and its enhancement by retinoic acid in primary human neuro-and Milbrandt, J. (1997). TrnR2, a novel receptor that mediates neur-
blastomas expressing c-Ret, GFRa-1, and GFRa-2 Cancer Res. 58,turin and GDNF signaling through Ret. Neuron 18, 793±802.
2158±2165.
Baloh, R.H., Gorodinsky, A., Golden, J.P., Tansey, M.G., Keck, C.L.,
Horger, B.A., Nishimura, M.C., Armanini, M.P., Wang, L.C., Poulsen,Popescu, N.C., Johnson, E.M., Jr., and Milbrandt, J. (1998). GFRa3
K.T., Rosenblad, C., Kirik, D., Moffat, B., Simmons, L., Johnson, E.,is an orphan member of the GDNF/neurturin/persephin receptor
Jr., et al. (1998). Neurturin exerts potent actions on survival and
family. Proc. Natl. Acad. Sci. USA 95, 5801±5806.
function of midbrain dopaminergic neurons. J. Neurosci. 18, 4929±
Bennett, D.L., Michael, G.J., Ramachandran, N., Munson, J.B., Ave- 4937.
rill, S., Yan, Q., McMahon, S.B., and Priestley, J.V. (1998). A distinct
Ip, N.Y., Stitt, T.N., Tapley, P., Klein, R., Glass, D.J., Fandl, J., Greene,
subgroup of small DRG cells express GDNF receptor components L.A., Barbacid, G.D., and Yancopoulos, G.D. (1993). Similarities and
and GDNF is protective for these neurons after nerve injury. J. Neu- differences in the way neurotrophins interact with the Trk receptors
rosci. 18, 3059±3072. in neuronal and nonneuronal cells. Neuron 10, 137±149.
Brewer, C.B. (1994). Cytomegalovirus plasmid vectors for perma- Jing, S., Wen, D., Yu, Y., Holst, P.L., Luo, Y., Fang, M., Tamir, R.,
nent lines of polarized epithelial cells. Meth. Cell Biol. 43, 233±245. Antonio, L., Hu, Z., Cupples, R., et al. (1996). GDNF-induced activa-
Brockes, J.P., Fields, K.L., and Raff, M.C. (1979). Studies on cultured tion of the ret protein tyrosine kinase is mediated by GDNFR-a, a
rat Schwann cells. I. Establishment of purified populations from novel receptor for GDNF. Cell 85, 1113±1124.
cultures of peripheral nerves. Brain Res. 165, 105±118. Jing, S., Yu, Y., Fang, M., Hu, Z., Holst, P.L., Boone, T., Delaney, J.,
Buj-Bello, A., Buchman, V.L., Horton, A., Rosenthal, A., and Davies, Schultz, H., Zhou, R., and Fox, G.M. (1997). GFRa-2 and GFRa-3
A.M. (1995). GDNF is an age-specific survival factor for sensory and are two new receptors for ligands of the GDNF family. J. Biol. Chem.
272, 33111±33117.autonomic neurons. Neuron 15, 821±828.
Neuron
1302
Klein, R.D., Sherman, D., Ho, W.H., Stone, D., Bennett, G.l., Moffat, Trupp, M., Ryden, M., Jornvall, H., Funakoshi, H., Timmusk, T., Are-
nas, E., and Ibanez, C.F. (1995). Peripheral expression and biologicalB., Vandlen, R., Simmons, L., Gu, Q., Hongo, J.A., et al. (1997). A GPI-
linked protein that interacts with Ret to form a candidate neurturin activities of GDNF, a new neurotrophic factor for avian and mamma-
lian peripheral neurons. J. Cell Biol. 130, 137±148.receptor. Nature 387, 717±721.
Kotzbauer, P.T., Lampe, P.A., Estus, S., Milbrandt, J., and Johnson, Trupp, M., Arenas, E., Fainzilber, M., Nilsson, A.-S., Sieber, B.-A.,
Grigoriou, M., Kilkenny, C., Salazar-Grueso, E., Pachnis, V., Arumae,E.M.J. (1994). Postnatal development of survival responsiveness in
rat sympathetic neurons to leukemia inhibitory factor and ciliary U., Sariola, H., Saarma, M., and Ibanez, C.F. (1996). Functional re-
ceptor for GDNF encoded by the c-ret proto-oncogene. Nature 381,neurotrophic factor. Neuron 12, 763±773.
785±789.Kotzbauer, P.T., Lampe, P.A., Heuckeroth, R.O., Golden, J.P., Cree-
don, D.J., Johnson, E.M., and Milbrandt, J.D. (1996). Neurturin, a Trupp, M., Belluardo, N., Funakoshi, H., and Ibanez, C. (1997).
relative of glial-cell-line-derived neurotrophic factor. Nature 384, Complementary and overlapping expression of glial cell line±derived
467±470. neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF
receptor-a indicates multiple mechanisms of trophic actions in theLewin, G.R., and Barde, Y.A. (1996). Physiology of the neurotrophins.
adult rat CNS. J. Neurosci. 17, 3554±3567.Annu. Rev. Neurosci. 19, 289±317.
Trupp, M., Raynoschek, C., Belluardo, N., and Ibanez, C.F. (1998).Lin, L.-F.H., Doherty, D.H., Lile, J.D., Bektesh, S., and Collins, F.
Multiple GPI-anchored receptors control GDNF-dependent and in-(1993). GDNF: a glial cell line±derived neurotrophic factor for mid-
dependent activation of the c-Ret receptor tyrosine kinase. Mol.brain dopaminergic neurons. Science 260, 1130±1132.
Cell. Neurosci. 11, 47±63.Lindsay, R.M., Thoenen, H., and Barde, Y.-A. (1985). Placode and
Vossler, M.R., Yao, H., York, R.D., Pan, M.G., Rim, C.S., and Stork,neural crest±derived sensory neurons are responsive at early devel-
P.J. (1997). cAMP activates MAP kinase and Elk-1 through a B-Raf-opmental stages to brain-derived neurotrophic factor. Dev. Biol.
and Rap1-dependent pathway. Cell 89, 73±82.112, 319±328.
Widenfalk, J., Tomac, A., Lindqvist, E., Hoffer, B., and Olson, L.Milbrandt, J., de Sauvage, F.J., Fahrner, T.J., Baloh, R.H., Leitner,
(1998). GFRa3, a protein related to GFRa1, is expressed in devel-M.L., Tansey, M.G., Lampe, P.A., Heuckeroth, R.O., Kotzbauer, P.T.,
oping peripheral neurons and ensheathing cells. Eur. J. Neurosci.Simburger, K.S., et al. (1998). Persephin, a novel neurotrophic factor
10, 1508±1517.related to GDNF and neurturin. Neuron 20, 245±253.
Worby, C.A., Vega, Q.C., Zhao, Y., Chao, H.H.-J., Seasholtz, A.F.,Molliver, D.C., Wright, D.E., Leitner, M.L., Parsadanian, A.S., Doster.
and Dixon, J.E. (1996). Glial cell line±derived neurotrophic factorK., Wen, D., Yan, Q., and Snider, W.D. (1997). IB4-binding DRG
signals through the RET receptor and activates the mitogen-acti-neurons switch from NGF to GDNF dependence in early postnatal
vated protein kinase. J. Biol. Chem. 271, 23619±23622.life. Neuron 19, 849±861.
Moore, M.W., Klein, R.D., Farinas, I., Sauer, H., Armanini, M., Phillips, Worby, C.A., Vega, Q.C., Chao, H.H., Seasholtz, A.F., Thompson,
H., Reichart, L.F., Ryan, A.M., Carver-Moore, K., and Rosenthal, A. R.C, and Dixon, J.E. (1998). Identification and characterization of
(1996). Renal and neuronal abnormalities in mice lacking GDNF. GFRa-3, a novel co-receptor belonging to the glial cell line±derived
Nature 382, 76±79. neurotrophic receptor family. J. Biol. Chem. 273, 3502±3508.
Naveilhan, P., Baudet, C., Mikaels, A., Shen, L., Westphal, H., and York, R.D., Yao, H., Dillon, T., Ellig, C.L., Eckert, S.P., McCleskey,
Ernfors, P. (1998). Expression and regulation of GFRa3, a glial cell E.W., and Stork, P.J. (1998). Rap1 mediates sustained MAP kinase
line±derived neurotrophic factor family receptor. Proc. Natl. Acad. activation induced by nerve growth factor. Nature 392, 622±626.
Sci. USA 95, 1295±1300. Yu, T., Scully, S., Yu, Y., Fox, G.M., Jing, S., and Zhou, R. (1998).
Oppenheim, R.W., Houenou, L.J., Johnson, J.E., Lin, L.-F.H., Li, Expression of GDNF family receptor components during develop-
L., Lo, A.C., Newsome, A.L., Prevette, D.M., and Wang, S. (1995). ment: implications in the mechanisms of interaction. J. Neurosci.
Developing motor neurons rescued from programmed and axotomy- 18, 4684±4696.
induced cell death by GDNF. Nature 373, 344±346.
GenBank Accession NumbersPichel, J.G., Shen, L., Hui, S.Z., Granholm, A.-C., Drago, J., Grinberg,
A., Lee, E.J., Huang, S.P., Saarma, M., Hoffer, B.J., et al. (1996).
The sequence of human Artemin cDNA has been submitted to Gen-Defects in enteric innervation and kidney development in mice lack-
Bank under accession number AF109401; the sequence of mouseing GDNF. Nature 382, 73±76.
Artemin cDNA has been submitted under accession numberSanchez, M.P., Silos-Santiago, I., Frisen, J., He, B., Lira, S.A., and
AF109402.Barbacid, M. (1996). Renal agenesis and the absence of enteric
neurons in mice lacking GDNF. Nature 382, 70±73.
Sanicola, M., Hession, C., Worley, D., Carmillo, P., Ehrenfels, C.,
Walus, L., Robinson, S., Jaworski, G., Wei, H., Tizard, R., et al. (1997).
Glial cell line±derived neurotrophic factor±dependent RET activation
can be mediated by two different cell-surface accessory proteins.
Proc. Natl. Acad. Sci., USA 94, 6238±6243.
Scherer, S.S. (1997). The biology and pathobiology of Schwann cells.
Curr. Opin. Neurol. 10, 386±397.
Snider, W.D., and Wright, D.E. (1996). Neurotrophins cause a new
sensation. Neuron 16, 229±232.
Suvanto, P., Wartiovaara, K., Lindahl, M., Arumae, U., Moshnyakov,
M., Horelli-Kuitunen, N., Airaksinen, M.S., Palotie, A., Sariola, H., and
Saarma, M. (1997). Cloning, mRNA distribution and chromosomal
localisation of the gene for glial cell line±derived neurotrophic factor
receptor b, a homologue to GDNFR-a. Hum. Mol. Genet. 6, 1267±
1273.
Svaren, J., Sevetson, B.R., Golda, T., Stanton, J.J., Swirnoff, A.H.,
and Milbrandt, J. (1998). Novel mutants of NAB corepressors en-
hance activation by Egr transactivators. EMBO J. 17, 6010±6019.
Treanor, J.J.S., Goodman, L., Sauvage, F., Stone, D.M., Poulsen,
K.T., Beck, C.D., Gray, C., Armanini, M.P., Pollock, R.A., Hefti, F., et
al. (1996). Characterization of a multicomponent receptor for GDNF.
Nature 382, 80±83.
